As a result of aging population, the incidence of pelvic insufficiency fracture has been increasing. Pain-related immobility caused by pelvic insufficiency fractures may result in a serious dependency and high mortality with preexisting comorbidities. We present two cases of pelvic insufficiency fracture in elderly patients which had good clinical outcome by parathyroid hormone 1-34(teriparatide) treatment as well as a literature review.
INTRODUCTION
Pelvic insufficiency fractures are common in female patients with osteoporosis and mostly occurred by trivial injury or slip down. As elderly population increases, the incidence of pelvic insufficiency fractures tends to be also increased rapidly. [1, 2] If pelvic insufficiency fractures occur in elderly population, it leads to increase in dependency by mobility reduction in patients and then mortality rate also increases due to aggravation of medical comorbidities. [3] However, diagnosis and treatments are easily missed for the pelvic insufficiency fractures occurred in elderly population.
The aim of treatments for pelvic insufficiency fractures is to let patients walk early with bed rest and medication for pain relief. As we obtained outstanding clinical outcome such as early pain relief and walk utilizing parathyroid hormone (PTH) 1-34(teriparatide) in pelvic insufficiency fractures, we present the cases as well as a literature review.
CASE REPORT

Case 1
The patient was a 76 year old female and visited outpatient clinic due to the left hip pain that was occurred after a fall (slip down). Fractures in left pubic ramus were observed on simple radiograph at the admission and fractures in sacrum left side were found in bone single photon emission computed tomography (SPECT) and computed tomography (CT) scan (Fig. 1) . In bone mineral density examination utilizing dual-energy X-ray absorptiometry analogue scale (VAS) was 7 at the time of admission and then decreased to 3 two weeks after the administration.
The patient was able to move using a wheelchair a week after the injury and walked using a walker 10 days after the injury. Then, the patient was able to walk herself without 
Case 2
Eighty two years old female visited outpatient clinic due to the pain on the right buttock that was occurred after a fall (slip down) on her behind. Simple radiograph at the time of her visiting indicated fractures in right pubic ramus and CT scan showed fractures in sacrum left side (Fig. 3) .
Osteoporosis with T-score -3.3 (L1-4) was observed, but the patient had never diagnosed and treated for osteoporosis before the injury. VAS was 7 at the time of admission and then decreased to 2 two weeks after the administration (three weeks after the injury). The patient was able to ambulate with a wheelchair three weeks after the injury and walked independently without a walker four weeks after the injury. On simple radiograph four weeks after the injury, callus formation was observed in right pubic ramus and then it was even definitely denser on 3 months follow-up x-ray (Fig. 4) . It was reported that incidence rate of pelvic insufficiency fractures is one third to one fourth of hip fractures. [4] According to an recent epidemiological study, however, the incidence rate of pelvic insufficiency fractures increased from 20 every 100,000 people in 1970 to 92 every 100,000 people in 1997 for patients more than 60 years old and from 1997 to 2002, it increase 5.3 times. [2] In addition to the incidence rate, mortality rate of pelvic insufficiency fractures is also comparable with hip fractures; recent studies reported that annual mortality rate of pelvic insufficiency fractures is 16.3% on average which is similar to annual mortality rate of hip fractures. [3] As pelvic insufficiency fractures hardly have secondary displacement or nonunion, bed rest and medication for pain relief are typical treatment. Therefore, in case where sufficient medication is hard to be carried out, surgical treatments such as ramoplasty [5] or sacroplasty [7] can be performed in order to relieve pains in early stage thereby improving mobility of patients.
DISCUSSION
Recently, many animal studies have proved that when PTH was injected, enchondral ossification and callus formation occur rapidly as accelerating cartilage differentiation, indicating that PTH facilitates fracture healing. [8] It is reported that callus developed by administration of PTH possesses superior bone quality and mechanical strength compared to the callus observed when administering bisphosphonate agents. [9] For osteoporosis patients with pelvic insufficiency fractures, we performed typical treatment bed rest and analgesics for pelvic insufficiency fractures and administered PTH 1-34(teriparatide) for osteoporosis. In the present cases, we experienced that PTH 1-34(teriparatide) was effective in callus formation as well as treatment of osteoporosis. This is also in agreement with a clinical study that when pelvic insufficiency fractures was treated with PTH derivatives, fracture healing were promoted and duration of bed rest was shortened as treatment duration was reduced. [4] In present two cases, PTH 1-34(teriparatide) was administered for two months and then replaced with bisphosphonate due to financial reasons. Decrease in callus formation or reccurrence of pains didn't happen after terminating the PTH. Weber et al. [10] reported that pains were continued for 9 weeks when pelvic insufficiency fractures were treated with bed rest and analgesics and the authors also had similar results with the same treatment.
We confirmed that pain relief and callus formation were relatively faster when analgesic was administered with PTH 1-34(teriparatide) in our cases. Effectiveness of analgesics such as fentanyl patch can't be ruled out for rapid pain relief and two cases are not enough to conclude that the treatment was facilitated. Therefore, additional studies as control groups are required in order to conclude the effectiveness of treatment with PTH 1-34(teriparatide). In conclusion, PTH 1-34(teriparatide) treatment is considered to be useful to relieve pain rapidly, to allow walk in early stage, and to reduce side effects caused by drug administration in pelvic insufficiency fracture patients with osteoporosis.
